RxDoctor Payments Data

Margaret Kilgore, APRN

Adult Health · Louisville, KYNPI 1740608082

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,102 of the $1,389 with a category attached, or 79.3%. 12 manufacturers reported payments, led by Galderma Laboratories, L.p. at 39.5% of the total.

$1,389in general payments, 2019–2025

Across 43 payments — averaging $32.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Galderma Laboratories, L.p.$549
  • Sun Pharmaceutical Industries Inc.$192
  • Johnson & Johnson$157
  • AbbVie$155
  • Dermavant Sciences, Inc.$62
  • Amgen$58
  • plus $216 from 6 others

What the payments were for

  • Food & beverage$1,10279%
  • Education$28721%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,389 in reported general payments places this provider in the 70th percentile of 170 adult health providers in Kentucky.

See all adult health providers in Kentucky

Medicare billing

Part B allowed, 2024
$165,758
Medicare patients
762
Services billed
3,926

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluorouracil86$6,901
Clobetasol Propionate101$2,925
Imiquimod61$1,738
Metronidazole27$1,707
Tretinoin22$1,600
Ketoconazole133$1,431
CiclopiroxCiclopirox Olamine21$1,346
Tacrolimus15$1,270
Triamcinolone Acetonide130$946
Clindamycin Phosphate26$839
Fluocinonide16$792
Fluocinolone Acetonide Oil22$701
Nystatin-TriamcinoloneNystatin/Triamcinolone Acet12$462
Mupirocin73$356
Finasteride19$185

Paid to pharmacies, not to this prescriber.

Other adult health in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →